SequelSEC

LEMAITRE VASCULAR INC LMAT

Surgical & Medical Instruments & Apparatus · CIK 0001158895 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$262.43M
Fiscal year ended 2026-06-30
Operating income
$77.32M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

LEMAITRE VASCULAR INC (LMAT) reported revenue of $262.43M and net income of $65.67M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from LEMAITRE VASCULAR INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

LEMAITRE VASCULAR INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$262.43M
Cost of revenue$71.13M
Gross profit$191.30M
Operating income$77.32M
Net income$65.67M
Research & development$15.41M
Weighted-average diluted sharesUnavailable
Pretax income$84.73M
Income tax expense$19.06M
Diluted EPS$2.85
Selling, general & administrative$98.58M
General & administrative$44.30M
Selling & marketing$54.28M

Balance

LEMAITRE VASCULAR INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$26.62M
Total assets$640.55M
Current assets$488.30M
Total liabilities$220.21M
Current liabilities$29.94M
Total equity incl. NCI$420.34M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivable$35.68M
Goodwill$65.94M
Long-term debtUnavailable
Accounts payable$3.24M

Cash flow

LEMAITRE VASCULAR INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$82.98M
Capital expendituresUnavailable
Investing cash flow-$68.47M
Financing cash flow-$14.81M
Net change in cash-$552.00K
Stock-based compensation$7.86M
Common dividends paid$20.50M
Common share repurchases$1.69M
Depreciation & amortization$10.50M

Derived

LEMAITRE VASCULAR INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin72.9%
Operating margin29.5%
FCF marginUnavailable
SBC / revenue3.0%
Current ratio16.31x
Revenue YoY growth11.8%
Net margin25.0%
R&D / revenue5.9%
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rate22.5%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LMAT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.